arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Hyperfine, Inc.

HYPR
$0.69 ▼ -0.06 (-8.04%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
7 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

Hyperfine, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $56.4M
Dividend Yield —
Revenue Growth 5.2% ↘
Op. Margin -273.4% ↗
ROIC -90.4% ↘
FCF / Share $-0.36 ↗
Trailing P/E —
Price / Book 1.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.56M
↑ +5.2% —
Net Income Profit after all expenses
$-35.57M
↑ +12.6% —
Operating Margin Operating profit as % of sales
-273.4%
↑ +18.5% 0th
FCF / Share Free cash flow per share
$-0.36
↑ +34.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
1
Returns ↓
11
Cash Quality ↑
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 24 quarters